{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:50:52Z","timestamp":1790704252605,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["737.016.022"],"award-info":[{"award-number":["737.016.022"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jlr.2022.100199","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T20:17:29Z","timestamp":1647634649000},"page":"100199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish."],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5584-7266","authenticated-orcid":false,"given":"Lindsey T.","family":"Lelieveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gerhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley C.","family":"Zwiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst H.","family":"Beijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-3902","authenticated-orcid":false,"given":"Marta","family":"Artola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1325-0725","authenticated-orcid":false,"given":"Annemarie H.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Tudorache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7031-3390","authenticated-orcid":false,"given":"Rolf G.","family":"Boot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2022.100199_bib1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2022.100199_bib2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s10354-010-0814-1","article-title":"Laboratory and genetic evaluation of Gaucher disease","volume":"160","author":"Bodamer","year":"2010","journal-title":"Wien Med. Wochenschr."},{"key":"10.1016\/j.jlr.2022.100199_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","article-title":"Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria","volume":"379","author":"Mechtler","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2022.100199_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/jpm-2013-0113","article-title":"Austrian newborn screening program: a perspective of five decades","volume":"42","author":"Pollak","year":"2014","journal-title":"J.\u00a0Perinat. Med."},{"key":"10.1016\/j.jlr.2022.100199_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jlr.2022.100199_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2022.100199_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-019-0336-2","article-title":"Glucocerebrosidase and its relevance to Parkinson disease","volume":"14","author":"Do","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jlr.2022.100199_bib8","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.jlr.2022.100199_bib9","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2022.100199_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jlr.2022.100199_bib11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/2211-5463.12078","article-title":"Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models","volume":"6","author":"Kramer","year":"2016","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jlr.2022.100199_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10545-014-9711-x","article-title":"Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy","volume":"37","author":"van Dussen","year":"2014","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2022.100199_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bcmd.2005.05.005","article-title":"Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease","volume":"35","author":"Deegan","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.jlr.2022.100199_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bcmd.2016.12.002","article-title":"Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease","volume":"68","author":"Murugesan","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.jlr.2022.100199_bib15","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jlr.2022.100199_bib16","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2014-09-600270","article-title":"Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation","volume":"125","author":"Nair","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jlr.2022.100199_bib17","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/hmg\/ddz030","article-title":"GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease","volume":"28","author":"Ikuno","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2022.100199_bib18","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","article-title":"Glucosylsphingosine promotes alpha-synuclein pathology in mutant GBA-associated Parkinson's disease","volume":"37","author":"Taguchi","year":"2017","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jlr.2022.100199_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ymgme.2018.06.007","article-title":"Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease","volume":"124","author":"Reed","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jlr.2022.100199_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/path.4992","article-title":"Reduced cerebral vascularization in experimental neuronopathic Gaucher disease","volume":"244","author":"Smith","year":"2018","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.jlr.2022.100199_bib21","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3390\/ijms18102192","article-title":"Glucosylsphingosine causes hematological and visceral changes in mice-evidence for a pathophysiological role in Gaucher disease","volume":"18","author":"Lukas","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2022.100199_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/mt.2015.16","article-title":"Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice","volume":"23","author":"Dahl","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jlr.2022.100199_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcmd.2010.07.009","article-title":"The cytosolic beta-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation","volume":"46","author":"Dekker","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.jlr.2022.100199_bib24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases","volume":"590","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jlr.2022.100199_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/oxfordjournals.jbchem.a124584","article-title":"The synthetic pathway for glucosylsphingosine in cultured fibroblasts","volume":"116","author":"Yamaguchi","year":"1994","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.jlr.2022.100199_bib26","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.bbamem.2006.08.019","article-title":"Acid ceramidase and human disease","volume":"1758","author":"Park","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2022.100199_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13023-018-0845-z","article-title":"Acid ceramidase deficiency: farber disease and SMA-PME","volume":"13","author":"Yu","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jlr.2022.100199_bib28","doi-asserted-by":"crossref","first-page":"29948","DOI":"10.1074\/jbc.M303310200","article-title":"The reverse activity of human acid ceramidase","volume":"278","author":"Okino","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100199_bib29","doi-asserted-by":"crossref","first-page":"11098","DOI":"10.1074\/jbc.270.19.11098","article-title":"Purification, characterization, and biosynthesis of human acid ceramidase","volume":"270","author":"Bernardo","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100199_bib30","doi-asserted-by":"crossref","first-page":"35352","DOI":"10.1074\/jbc.M103066200","article-title":"Human acid ceramidase: processing, glycosylation, and lysosomal targeting","volume":"276","author":"Ferlinz","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100199_bib31","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41467-018-03844-2","article-title":"Structural basis for the activation of acid ceramidase","volume":"9","author":"Gebai","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2022.100199_bib32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/acs.jmedchem.8b01723","article-title":"Molecular mechanism of inhibition of acid ceramidase by carmofur","volume":"62","author":"Dementiev","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jlr.2022.100199_bib33","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1194\/jlr.RA119000154","article-title":"Role of beta-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish","volume":"60","author":"Lelieveld","year":"2019","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100199_bib34","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/jacs.9b00056","article-title":"Functionalized cyclophellitols are selective glucocerebrosidase inhibitors and induce a Bona fide neuropathic Gaucher model in zebrafish","volume":"141","author":"Artola","year":"2019","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jlr.2022.100199_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijbiomac.2018.10.222","article-title":"Zebrafish acid ceramidase: expression in Pichia pastoris GS115and biochemical characterization","volume":"122","author":"Rajput","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jlr.2022.100199_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1","volume":"91","author":"Zhou","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jlr.2022.100199_bib37","doi-asserted-by":"crossref","first-page":"19939","DOI":"10.1038\/s41598-019-56466-z","article-title":"Parallel Reaction Monitoring reveals structure-specific ceramide alterations in the zebrafish","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2022.100199_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1194\/jlr.M064923","article-title":"Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular beta-glucosidases","volume":"57","author":"Marques","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100199_bib39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cca.2017.01.014","article-title":"Simultaneous quantitation of sphingoid bases by UPLC-ESI-MS\/MS with identical (13)C-encoded internal standards","volume":"466","author":"Mirzaian","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jlr.2022.100199_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gr.4791006","article-title":"Genetic variation in the zebrafish","volume":"16","author":"Guryev","year":"2006","journal-title":"Genome Res."},{"key":"10.1016\/j.jlr.2022.100199_bib41","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100199_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cne.22213","article-title":"Expression of the paralogous tyrosine hydroxylase encoding genes th1 and th2 reveals the full complement of dopaminergic and noradrenergic neurons in zebrafish larval and juvenile brain","volume":"518","author":"Filippi","year":"2010","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.jlr.2022.100199_bib43","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1093\/hmg\/ddv369","article-title":"Glucocerebrosidase 1 deficient danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death","volume":"24","author":"Keatinge","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2022.100199_bib44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41587-019-0036-z","article-title":"SignalP 5.0 improves signal peptide predictions using deep neural networks","volume":"37","author":"Almagro Armenteros","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jlr.2022.100199_bib45","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jlr.2022.100199_bib46","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jlr.2022.100199_bib47","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1107\/S0907444911007281","article-title":"Presenting your structures: the CCP4mg molecular-graphics software","volume":"67","author":"McNicholas","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jlr.2022.100199_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.margen.2013.10.004","article-title":"Presence of two tumor necrosis factor (tnf)-alpha homologs on different chromosomes of zebrafish (Danio rerio) and medaka (Oryzias latipes)","volume":"13","author":"Kinoshita","year":"2014","journal-title":"Mar. Genomics"},{"key":"10.1016\/j.jlr.2022.100199_bib49","series-title":"De L\u2019epithelioma Primitif de la Rate","author":"Gaucher","year":"1882"},{"key":"10.1016\/j.jlr.2022.100199_bib50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A\u00a0review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2022.100199_bib51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2022.100199_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fcell.2019.00012","article-title":"Resident immunity in tissue repair and maintenance: the zebrafish model coming of age","volume":"7","author":"Martins","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jlr.2022.100199_bib53","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100199_bib54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fnins.2015.00417","article-title":"Neuroinflammatory paradigms in lysosomal storage diseases","volume":"9","author":"Bosch","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jlr.2022.100199_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12974-020-01934-x","article-title":"Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease","volume":"17","author":"Vardi","year":"2020","journal-title":"J.\u00a0Neuroinflam."},{"key":"10.1016\/j.jlr.2022.100199_bib56","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/jnc.15136","article-title":"Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease","volume":"156","author":"Blumenreich","year":"2021","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2022.100199_bib57","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1074\/jbc.M111.308312","article-title":"Hypokinesia and reduced dopamine levels in zebrafish lacking beta- and gamma1-synucleins","volume":"287","author":"Milanese","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100199_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005065","article-title":"Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein","volume":"11","author":"Uemura","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jlr.2022.100199_bib59","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/sctm.20-0386","article-title":"Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1","volume":"10","author":"Srikanth","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jlr.2022.100199_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fneur.2018.00347","article-title":"Zebrafish as an animal model for drug discovery in Parkinson's disease and other movement disorders: a systematic review","volume":"9","author":"Vaz","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jlr.2022.100199_bib61","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/hmg\/ddx120","article-title":"Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration","volume":"26","author":"Soria","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2022.100199_bib62","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.celrep.2016.07.085","article-title":"Identification of modifier genes in a mouse model of Gaucher disease","volume":"16","author":"Klein","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2022.100199_bib63","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/srep01035","article-title":"Discovery of highly potent acid ceramidase inhibitors with in\u00a0vitro tumor chemosensitizing activity","volume":"3","author":"Realini","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2022.100199_bib64","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1039\/C5CC00356C","article-title":"Development of an acid ceramidase activity-based probe","volume":"51","author":"Ouairy","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jlr.2022.100199_bib65","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1021\/jacs.8b11687","article-title":"Activity-based imaging of acid ceramidase in living cells","volume":"141","author":"Ordonez","year":"2019","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jlr.2022.100199_bib66","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/epi.12977","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy: a rare condition caused by mutations in ASAH1","volume":"56","author":"Rubboli","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.jlr.2022.100199_bib67","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2015.12.006","article-title":"Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders","volume":"117","author":"Ferraz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jlr.2022.100199_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114669","article-title":"Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study","volume":"9","author":"Welford","year":"2014","journal-title":"PLoS one"},{"key":"10.1016\/j.jlr.2022.100199_bib69","doi-asserted-by":"crossref","first-page":"20097","DOI":"10.1073\/pnas.1912108116","article-title":"Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100199_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136442","article-title":"Epithelial-mesenchymal transition in kidney tubular epithelial cells induced by globotriaosylsphingosine and globotriaosylceramide","volume":"10","author":"Jeon","year":"2015","journal-title":"PLoS one"},{"key":"10.1016\/j.jlr.2022.100199_bib71","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.112.195685","article-title":"Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine","volume":"60","author":"Rombach","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jlr.2022.100199_bib72","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/ndt\/gfq306","article-title":"Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy","volume":"26","author":"Sanchez-Nino","year":"2011","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jlr.2022.100199_bib73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.gep.2014.01.001","article-title":"Spatial and temporal expression patterns of chitinase genes in developing zebrafish embryos","volume":"14","author":"Koch","year":"2014","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.jlr.2022.100199_bib74","article-title":"TNF signaling and macrophages govern fin regeneration in zebrafish larvae","volume":"8","author":"Nguyen-Ch","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jlr.2022.100199_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28511-w","article-title":"Interleukin 10 mutant zebrafish have an enhanced interferon gamma response and improved survival against a Mycobacterium marinum infection","volume":"8","author":"Harjula","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2022.100199_bib76","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1745-7270.2007.00283.x","article-title":"Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization","volume":"39","author":"Tang","year":"2007","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:57:19Z","timestamp":1777435039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227522000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0022227522000323"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100199","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish.","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100199"}}